Atypical adenomatous hyperplasia (AAH) has been suggested as the adenoma in
an adenoma-carcinoma sequence in the lung periphery. From 1989-1998, we un
dertook a systematic, prospective search for AAH in lungs resected for canc
er. AAH was found in 57 of 554 patients (12.1%) with primary lung carcinoma
(9.2% in male patients and 19.0% in females). AAH was found in lungs beari
ng adenocarcinoma (23.2%) more frequently than with large cell undifferenti
ated carcinoma (12.5%) or squamous carcinoma (3.3%). A greater percentage o
f females with adenocarcinoma had AAH (30.2%) than did males with adenocarc
inoma (18.8%). Numbers of AAH ranged from 1-42 per patient and more patient
s had small numbers of AAH, although 12 patients had 6 or more AAH foci, La
rger numbers of AAH tended to be found in adenocarcinoma-bearing lungs. Ten
of the 67 patients with AAH and primary lung carcinoma (15%) had multiple
primary cancers (range 2-6), all of which were adenocarcinoma. Synchronous
cancers were rare in lung tumour-bearing resections without AAH. Patients w
ith AAH show no difference in post-operative survival to those without, for
all stages of carcinoma and for Stage I disease alone. This study provides
evidence for a strong association between atypical adenomatous hyperplasia
and primary lung adenocarcinoma and lends weight to the AAH/adenoma-carcin
oma hypothesis. (C) 2000 Cancer Research Campaign.